Literature DB >> 11188968

Mechanism of action of deep brain stimulation.

A Benazzouz1, M Hallett.   

Abstract

Initial observations in patients with tremor treated with deep brain stimulation (DBS) of the thalamus suggested that application of high-frequency stimulation (HFS) had a lesion-like effect. New clinical information from patients treated with DBS of the subthalamic nucleus (STN) and globus pallidus internus (GPi) suggested a more complex mechanism of action. Recent experiments in the rat have shown that HFS of the STN was accompanied by increased release of glutamate and dopamine in the substantia nigra and striatum, respectively. Observations made in the GPi of parkinsonian patients during surgery suggest that stimulation may excite GABA release in axons from afferent connections. Therefore, although depolarization block may remain a major mechanism of action, generation of action potentials and release of neurotransmitters may also be involved in the therapeutic effects of DBS in Parkinson's disease.

Entities:  

Mesh:

Year:  2000        PMID: 11188968

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  59 in total

1.  Defining a role for the subthalamic nucleus within operative theoretical models of subcortical participation in language.

Authors:  B-M Whelan; B E Murdoch; D G Theodoros; B Hall; P Silburn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

2.  Chronic high-frequency stimulation therapy in hemiparkinsonian rhesus monkeys using an implanted human DBS system.

Authors:  Yiqun Cao; Peihao Yin; Xiaowu Hu; Yiqin Ge; Xiaoping Zhou
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

3.  Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts.

Authors:  F Godinho; S Thobois; M Magnin; M Guenot; G Polo; I Benatru; J Xie; A Salvetti; L Garcia-Larrea; E Broussolle; P Mertens
Journal:  J Neurol       Date:  2006-06-20       Impact factor: 4.849

4.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

5.  Electrical stimulation for the suppression of pathological tremor.

Authors:  Lana Popović Maneski; Nikola Jorgovanović; Vojin Ilić; Strahinja Došen; Thierry Keller; Mirjana B Popović; Dejan B Popović
Journal:  Med Biol Eng Comput       Date:  2011-07-14       Impact factor: 2.602

6.  Deep brain stimulation of the globus pallidus internus in the parkinsonian primate: local entrainment and suppression of low-frequency oscillations.

Authors:  Kevin W McCairn; Robert S Turner
Journal:  J Neurophysiol       Date:  2009-01-21       Impact factor: 2.714

Review 7.  Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.

Authors:  R Christopher Pierce; Fair M Vassoler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-02       Impact factor: 4.530

8.  Are there adaptive changes in the human brain of patients with Parkinson's disease treated with long-term deep brain stimulation of the subthalamic nucleus? A 4-year follow-up study with regional cerebral blood flow SPECT.

Authors:  Stelvio Sestini; Alberto Pupi; Franco Ammannati; Ramat Silvia; Sandro Sorbi; Antonio Castagnoli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-04       Impact factor: 9.236

Review 9.  Neurocomputational models of basal ganglia function in learning, memory and choice.

Authors:  Michael X Cohen; Michael J Frank
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

10.  GABA(A) autoreceptors enhance GABA release from human neocortex: towards a mechanism for high-frequency stimulation (HFS) in brain?

Authors:  Michela Mantovani; Andreas Moser; Carola A Haas; Josef Zentner; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.